Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Safety and Efficacy of Steroid Pulse Therapy for Acute Loss of FEV1 in Lung Transplant Recipients After Exclusion of Acute Cellular Rejection.

Munker D, Arnold P, Veit T, Leuschner G, Ceelen F, Barnikel M, Schmitzer M, Barton J, Sonneck T, Milger K, Matthes S, Schiopu S, Kauke T, Weig T, Kneidinger N, Behr J, Neurohr C.

Transplant Proc. 2020 Jan - Feb;52(1):309-314. doi: 10.1016/j.transproceed.2019.10.013. Epub 2020 Jan 8.

PMID:
31926742
2.

Age- and sex-dependent differences in patients with severe asthma included in the German Asthma Net cohort.

Milger K, Korn S, Buhl R, Hamelmann E, Herth FJ, Gappa M, Drick N, Fuge J, Suhling H.

Respir Med. 2020 Feb;162:105858. doi: 10.1016/j.rmed.2019.105858. Epub 2020 Jan 3.

PMID:
31916535
3.

Feasibility and accuracy of SPECT myocardial perfusion imaging in end-stage lung disease.

Schiopu SRI, Zacherl M, Todica A, Bartenstein P, Milger K, Leuschner G, Munker D, Bauer M, Massberg S, Behr J, Neurohr C, Huber BC, Kneidinger N.

J Nucl Cardiol. 2019 Aug 19. doi: 10.1007/s12350-019-01851-4. [Epub ahead of print]

PMID:
31428982
4.

Effect of Acute Altitude Exposure on Serum Markers of Platelet Activation.

Lackermair K, Schuhmann CG, Mertsch P, Götschke J, Milger K, Brunner S.

High Alt Med Biol. 2019 Sep;20(3):318-321. doi: 10.1089/ham.2018.0112. Epub 2019 Aug 14.

PMID:
31411500
5.

Letermovir for Difficult to Treat Cytomegalovirus Infection in Lung Transplant Recipients.

Veit T, Munker D, Kauke T, Zoller M, Michel S, Ceelen F, Schiopu S, Barton J, Arnold P, Milger K, Behr J, Kneidinger N.

Transplantation. 2020 Feb;104(2):410-414. doi: 10.1097/TP.0000000000002886.

PMID:
31385924
6.

Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation.

Veit T, Leuschner G, Sisic A, Ceelen F, Munker D, Schmitzer M, Weig T, Michel S, Schneider C, Meiser B, Crispin A, Neurohr C, Behr J, Milger K, Kneidinger N.

Am J Transplant. 2019 Aug;19(8):2358-2365. doi: 10.1111/ajt.15378. Epub 2019 Apr 29.

PMID:
30942945
7.

Real-life data on Selexipag for the treatment of pulmonary hypertension.

Barnikel M, Kneidinger N, Klenner F, Waelde A, Arnold P, Sonneck T, Behr J, Neurohr C, Milger K.

Pulm Circ. 2019 Jan-Mar;9(1):2045894019832199. doi: 10.1177/2045894019832199.

8.

Asthma features in severe COPD: Identifying treatable traits.

Matthes S, Stadler J, Barton J, Leuschner G, Munker D, Arnold P, Villena-Hermoza H, Frankenberger M, Probst P, Koch A, Kneidinger N, Milger K, Behr J, Neurohr C.

Respir Med. 2018 Dec;145:89-94. doi: 10.1016/j.rmed.2018.10.027. Epub 2018 Oct 26.

PMID:
30509722
9.

Omalizumab Rescue Therapy for Refractory Status Asthmaticus.

Milger K, Schroeder I, Behr J, Meis T, Wulffen WV, Kneidinger N.

Ann Intern Med. 2019 Mar 5;170(5):351-352. doi: 10.7326/L18-0359. Epub 2018 Nov 20. No abstract available.

PMID:
30458534
10.

Daily Chronic Intermittent Hypobaric Hypoxia Does Not Induce Chronic Increase in Pulmonary Arterial Pressure Assessed by Echocardiography.

Götschke J, Mertsch P, Kneidinger N, Kauffmann-Guerrero D, Behr J, Huber RM, Reichenberger F, Milger K.

Can Respir J. 2018 Apr 1;2018:9649716. doi: 10.1155/2018/9649716. eCollection 2018.

11.

Intrauterine smoke exposure deregulates lung function, pulmonary transcriptomes, and in particular insulin-like growth factor (IGF)-1 in a sex-specific manner.

Dehmel S, Nathan P, Bartel S, El-Merhie N, Scherb H, Milger K, John-Schuster G, Yildirim AO, Hylkema M, Irmler M, Beckers J, Schaub B, Eickelberg O, Krauss-Etschmann S.

Sci Rep. 2018 May 15;8(1):7547. doi: 10.1038/s41598-018-25762-5.

12.

Impact of Nocturnal Noninvasive Ventilation on Pulmonary Rehabilitation in Patients with End-Stage Lung Disease Awaiting Lung Transplantation.

Kneidinger N, Gloeckl R, Schönheit-Kenn U, Milger K, Hitzl W, Behr J, Kenn K.

Respiration. 2018;95(3):161-168. doi: 10.1159/000484056. Epub 2017 Nov 21.

13.

Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancer.

Tufman A, Kahnert K, Duell T, Kauffmann-Guerrero D, Milger K, Schneider C, Stump J, Syunyaeva Z, Huber RM, Reu S.

Onco Targets Ther. 2017 Oct 25;10:5179-5186. doi: 10.2147/OTT.S140472. eCollection 2017.

14.

Perception of climate change in patients with chronic lung disease.

Götschke J, Mertsch P, Bischof M, Kneidinger N, Matthes S, Renner ED, Schultz K, Traidl-Hoffmann C, Duchna HW, Behr J, Schmude J, Huber RM, Milger K.

PLoS One. 2017 Oct 18;12(10):e0186632. doi: 10.1371/journal.pone.0186632. eCollection 2017.

15.

Development of a Stable Lung Microbiome in Healthy Neonatal Mice.

Kostric M, Milger K, Krauss-Etschmann S, Engel M, Vestergaard G, Schloter M, Schöler A.

Microb Ecol. 2018 Feb;75(2):529-542. doi: 10.1007/s00248-017-1068-x. Epub 2017 Sep 13.

PMID:
28905200
16.

Tidal Carbon Dioxide as a Prognostic Feature in Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Richter MJ, Tello K, Milger K, Ghofrani HA, Gall H.

Ann Am Thorac Soc. 2017 Oct;14(10):1603-1604. doi: 10.1513/AnnalsATS.201704-309LE. No abstract available.

PMID:
28806531
17.

Pulmonary CCR2+CD4+ T cells are immune regulatory and attenuate lung fibrosis development.

Milger K, Yu Y, Brudy E, Irmler M, Skapenko A, Mayinger M, Lehmann M, Beckers J, Reichenberger F, Behr J, Eickelberg O, Königshoff M, Krauss-Etschmann S.

Thorax. 2017 Nov;72(11):1007-1020. doi: 10.1136/thoraxjnl-2016-208423. Epub 2017 Aug 5.

PMID:
28780502
18.

Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approach.

Milger K, Götschke J, Krause L, Nathan P, Alessandrini F, Tufman A, Fischer R, Bartel S, Theis FJ, Behr J, Dehmel S, Mueller NS, Kneidinger N, Krauss-Etschmann S.

Allergy. 2017 Dec;72(12):1962-1971. doi: 10.1111/all.13205. Epub 2017 Jun 19.

PMID:
28513859
19.

Lung volumes predict survival in patients with chronic lung allograft dysfunction.

Kneidinger N, Milger K, Janitza S, Ceelen F, Leuschner G, Dinkel J, Königshoff M, Weig T, Schramm R, Winter H, Behr J, Neurohr C.

Eur Respir J. 2017 Apr 12;49(4). pii: 1601315. doi: 10.1183/13993003.01315-2016. Print 2017 Apr.

20.

Pulmonary microRNA profiles identify involvement of Creb1 and Sec14l3 in bronchial epithelial changes in allergic asthma.

Bartel S, Schulz N, Alessandrini F, Schamberger AC, Pagel P, Theis FJ, Milger K, Noessner E, Stick SM, Kicic A, Eickelberg O, Freishtat RJ, Krauss-Etschmann S.

Sci Rep. 2017 Apr 6;7:46026. doi: 10.1038/srep46026.

21.

The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups.

Gall H, Felix JF, Schneck FK, Milger K, Sommer N, Voswinckel R, Franco OH, Hofman A, Schermuly RT, Weissmann N, Grimminger F, Seeger W, Ghofrani HA.

J Heart Lung Transplant. 2017 Sep;36(9):957-967. doi: 10.1016/j.healun.2017.02.016. Epub 2017 Feb 17.

22.

Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer.

Tufman A, Kahnert K, Kauffmann-Guerrero D, Manapov F, Milger K, Müller-Lisse U, Winter H, Huber RM, Schneider C.

Strahlenther Onkol. 2017 May;193(5):392-401. doi: 10.1007/s00066-017-1118-9. Epub 2017 Feb 28.

PMID:
28246699
23.

D-tryptophan from probiotic bacteria influences the gut microbiome and allergic airway disease.

Kepert I, Fonseca J, Müller C, Milger K, Hochwind K, Kostric M, Fedoseeva M, Ohnmacht C, Dehmel S, Nathan P, Bartel S, Eickelberg O, Schloter M, Hartmann A, Schmitt-Kopplin P, Krauss-Etschmann S.

J Allergy Clin Immunol. 2017 May;139(5):1525-1535. doi: 10.1016/j.jaci.2016.09.003. Epub 2016 Sep 23.

PMID:
27670239
24.

Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis.

Bonella F, Kreuter M, Hagmeyer L, Neurohr C, Keller C, Kohlhaeufl MJ, Müller-Quernheim J, Milger K, Prasse A; German Nintedanib Compassionate Use Consortium.

Respiration. 2016;92(2):98-106. doi: 10.1159/000448288. Epub 2016 Aug 20.

25.

Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension.

Richter MJ, Milger K, Tello K, Stille P, Seeger W, Mayer E, Ghofrani HA, Gall H.

BMC Pulm Med. 2016 Jul 4;16(1):96. doi: 10.1186/s12890-016-0260-y.

26.

Suspected pulmonary embolism in patients with pulmonary fibrosis: Discordance between ventilation/perfusion SPECT and CT pulmonary angiography.

Leuschner G, Wenter V, Milger K, Zimmermann GS, Matthes S, Meinel FG, Lehner S, Neurohr C, Behr J, Kneidinger N.

Respirology. 2016 Aug;21(6):1081-7. doi: 10.1111/resp.12797. Epub 2016 Apr 7.

PMID:
27061739
27.

The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.

Richter MJ, Milger K, Haase S, Sommer N, Tello K, Seeger W, Mayer E, Wiedenroth CB, Grimminger F, George W, Ghofrani HA, Guth S, Gall H.

PLoS One. 2016 Mar 31;11(3):e0152580. doi: 10.1371/journal.pone.0152580. eCollection 2016.

28.

Core Muscle Size Predicts Postoperative Outcome in Lung Transplant Candidates.

Weig T, Milger K, Langhans B, Janitza S, Sisic A, Kenn K, Irlbeck T, Pomschar A, Johnson T, Irlbeck M, Behr J, Czerner S, Schramm R, Winter H, Neurohr C, Frey L, Kneidinger N.

Ann Thorac Surg. 2016 Apr;101(4):1318-25. doi: 10.1016/j.athoracsur.2015.10.041. Epub 2016 Jan 12.

PMID:
26794887
29.

Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study.

Gall H, Sommer N, Milger K, Richter MJ, Voswinckel R, Bandorski D, Seeger W, Grimminger F, Ghofrani HA.

BMC Pulm Med. 2016 Jan 12;16:5. doi: 10.1186/s12890-015-0164-2.

30.

Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF.

Milger K, Kneidinger N, Neurohr C, Reichenberger F, Behr J.

Eur Respir J. 2015 Oct;46(4):1217-21. doi: 10.1183/13993003.00584-2015. Epub 2015 Sep 4. No abstract available.

31.

Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension.

Milger K, Felix JF, Voswinckel R, Sommer N, Franco OH, Grimminger F, Reichenberger F, Seeger W, Ghofrani HA, Gall H.

Pulm Circ. 2015 Jun;5(2):305-12. doi: 10.1086/680355.

32.

Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism.

Milger K, Holdt LM, Teupser D, Huber RM, Behr J, Kneidinger N.

Int J Chron Obstruct Pulmon Dis. 2015 May 7;10:891-7. doi: 10.2147/COPD.S80173. eCollection 2015.

33.

Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient.

Kneidinger N, Giessen C, von Wulffen W, Milger K, Schramm R, Jäger G, Nitschko H, Striebinger H, Behr J, Neurohr C.

Int J Infect Dis. 2014 Nov;28:140-2. doi: 10.1016/j.ijid.2014.06.009. Epub 2014 Sep 26.

34.

Short-term improvement in pulmonary hemodynamics is strongly predictive of long-term survival in patients with pulmonary arterial hypertension.

Tiede H, Sommer N, Milger K, Voswinckel R, Bandorski D, Schermuly RT, Weissmann N, Grimminger F, Seeger W, Ghofrani HA.

Pulm Circ. 2013 Sep;3(3):523-32. doi: 10.1086/674338. Epub 2013 Nov 19.

35.

Cardiovocal Syndrome (Ortner's Syndrome) Associated with Chronic Thromboembolic Pulmonary Hypertension and Giant Pulmonary Artery Aneurysm: Case Report and Review of the Literature.

Heikkinen J, Milger K, Alejandre-Lafont E, Woitzik C, Litzlbauer D, Vogt JF, Klußmann JP, Ghofrani A, Krombach GA, Tiede H.

Case Rep Med. 2012;2012:230736. doi: 10.1155/2012/230736. Epub 2012 Oct 14.

36.

Clinician-scientist trainee: a German perspective.

Bossé D, Milger K, Morty RE.

Clin Invest Med. 2011 Dec 1;34(6):E324.

PMID:
22129920
37.

Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice.

Seimetz M, Parajuli N, Pichl A, Veit F, Kwapiszewska G, Weisel FC, Milger K, Egemnazarov B, Turowska A, Fuchs B, Nikam S, Roth M, Sydykov A, Medebach T, Klepetko W, Jaksch P, Dumitrascu R, Garn H, Voswinckel R, Kostin S, Seeger W, Schermuly RT, Grimminger F, Ghofrani HA, Weissmann N.

Cell. 2011 Oct 14;147(2):293-305. doi: 10.1016/j.cell.2011.08.035.

38.

Neurosyphilis manifesting with unilateral visual loss and hyponatremia: a case report.

Milger K, Fleig V, Kohlenberg A, Discher T, Lohmeyer J.

BMC Infect Dis. 2011 Jan 15;11:17. doi: 10.1186/1471-2334-11-17.

39.

Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4.

Milger K, Herrmann T, Becker C, Gotthardt D, Zickwolf J, Ehehalt R, Watkins PA, Stremmel W, Füllekrug J.

J Cell Sci. 2006 Nov 15;119(Pt 22):4678-88. Epub 2006 Oct 24.

Supplemental Content

Loading ...
Support Center